This brand name is authorized in Brazil, Ecuador, Spain, France, Tunisia
The drug GLUCANTIME contains one active pharmaceutical ingredient (API):
|
1
Meglumine
UNII 75G4TW236W - MEGLUMINE ANTIMONIATE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| P01CB01 | Meglumine antimonate | P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01C Agents against leishmaniasis and trypanosomiasis → P01CB Antimony compounds |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 502805502155311, 576720020056217 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 29574-1-01-11 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 17783 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 60576634 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6390041 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
